SCHEMBL27927319

SCHEMBL27927319

CC(=O)OCCc1c(C)n(C(N)=O)c2ccccc12

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAD52 P43351 1/20 0.51
▸ CNR1 P21554 3/20 0.42
▸ CNR2 P34972 3/20 0.42
▸ POLB P06746 1/20 0.41
▸ ABCB1 P08183 1/20 0.41
▸ PTGS1 P23219 1/20 0.41
▸ PTGS2 P35354 1/20 0.41
▸ GFER P55789 1/20 0.41
▸ PLA2G2A P14555 2/20 0.40
▸ HDAC6 Q9UBN7 1/20 0.38
▸ LMNA P02545 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ HTT P42858 1/20 0.36
▸ CFD P00746 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ TDP1 Q9NUW8 1/20 0.36
▸ ELANE P08246 1/20 0.36
▸ PTGIR P43119 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27817063 0.78 CNR2 (0.66) RAD52CNR1CNR2ABCB1PTGS1
SCHEMBL12480314 0.78 PTGS2 (0.47) CNR1CNR2ABCB1PTGS1PTGS2
SCHEMBL12480026 0.77 ABCB1 (0.64) ABCB1PTGS1PTGS2PLA2G2ALMNA
SCHEMBL27927349 0.73 RAD52 (0.42) RAD52HDAC6MAPTHTTCFD
SCHEMBL3088444 0.73 MAPT (0.50) POLBHDAC6LMNAMAPTHTT
SCHEMBL27721422 0.73 IL1R1 (0.47) CNR1CNR2POLBABCB1PTGS1
Hydrochloric Acid SCHEMBL28531727 0.71 MAPT (0.49) POLBHDAC6LMNAMAPTHTT
SCHEMBL14560446 0.71 RAD52 (0.49) RAD52KDM4EALDH1A1SMN1; SMN2TDP1
SCHEMBL27935661 0.70 IL1R1 (0.44) CNR1CNR2POLBABCB1PTGS1
SCHEMBL27927320 0.70 POLB (0.41) POLBLMNAMAPTHTTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103402996-A Indole compounds or analogues thereof useful for the treatment of age-related macular degeneration (AMD) NOVARTIS AG 2013-11-20 — — CN disclosed
Send feedback